Skip to main content
. 2020 Apr 30;122(12):1760–1768. doi: 10.1038/s41416-020-0846-2

Fig. 3. Box-plots demonstrating that baseline (pre-treatment) cytidine deaminase (CDA) activity did not predict for objective response or toxicity experienced by individual patients during treatment.

Fig. 3

a objective response (p of Kruskal–Wallis test = 0.62), (b) worst CTCAE grade experienced (p of Kruskal–Wallis test = 0.63) and (c) worst CTCAE neutropaenia grade experienced (p of Kruskal–Wallis test = 0.38).